ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Respiratory Tract Diseases
Chronic Obstructive Pulmonary Disease
Conjunctivitis
Dust Mite Allergy

Asthma trials near Taipei City, TWN:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 87 other locations

and clinical activity of FB704A in adult patients with severe asthma. The study comprised a 4-week screening period, a 8-week treatment peri...

Enrolling
Severe Asthma
Biological: FB704A
Biological: FB704A placebo

Phase 2

Oneness Biotech

Taipei, Taiwan and 8 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Taipei, Taiwan and 335 other locations

1. Eosinophilic asthma, a type 2 immune disorder, often involves the excessive production of type 2 cytokines.2. Excessive Type 2 cytokines ...

Not yet enrolling
Eosinophilic Asthma
Other: Formulation buffer
Biological: AD17002

Phase 2

Advagene Biopharma

Taipei, Taiwan, Taiwan

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Rocatinlimab

Phase 2

Amgen
Amgen

Taipei, Taiwan and 154 other locations

placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma...

Enrolling
Allergic Asthma
Biological: FB825
Other: Placebo

Phase 2

Oneness Biotech

Taipei, Taiwan and 15 other locations

per actuation manufactured by two different manufacturers using methacholine bronchoprovocation challenge test in patients with stable mild asthma...

Enrolling
Mild Asthma
Other: Methacholine
Other: Albuterol Sulfate inhalation Placebo
Intech Biopharm

Taipei City, Taiwan and 11 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Active, not recruiting
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

Taipei, Taiwan and 195 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Enrolling
Asthma
Drug: Short-Acting Beta Agonists (SABA)
Drug: Fluticasone/salmeterol

Phase 2

Sanofi
Sanofi

Taipei, Taiwan and 238 other locations

phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma...

Enrolling
Asthma
Drug: Placebo
Drug: Tozorakimab

Phase 2

AstraZeneca
AstraZeneca

Taipei, Taiwan and 206 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems